1. Home
  2. KYNB vs ITOC Comparison

KYNB vs ITOC Comparison

Compare KYNB & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

HOLD

Current Price

$2.16

Market Cap

32.8M

Sector

Health Care

ML Signal

HOLD

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$1.65

Market Cap

28.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KYNB
ITOC
Founded
1993
1998
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
28.1M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
KYNB
ITOC
Price
$2.16
$1.65
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $38.50
N/A
AVG Volume (30 Days)
22.5K
★ 24.8K
Earning Date
11-16-2026
03-19-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 9552.08
N/A
EPS
N/A
★ N/A
Revenue
★ $6,440,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.12
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.02
$0.22
52 Week High
$9.66
$4.49

Technical Indicators

Market Signals
Indicator
KYNB
ITOC
Relative Strength Index (RSI) 14.47 40.40
Support Level N/A $1.63
Resistance Level $7.47 $4.49
Average True Range (ATR) 0.42 0.42
MACD -0.08 -0.12
Stochastic Oscillator 4.56 13.11

Price Performance

Historical Comparison
KYNB
ITOC

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

Share on Social Networks: